Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
oxidative stress3585 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A22633 | 24395441 | J Cell Physiol | Protective effect of the Y220C mutant p53 against steatosis: good news? | 2014 | Details |
A22634 | 24393106 | Antioxid Redox Signal | Mitochondrial dysfunction in obesity-associated nonalcoholic fatty liver disease: the protective effects of pomegranate with its active component punicalagin. | 2014 | Details |
A22655 | 24379011 | Nutrients | Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention. | 2013 | Details |
A22661 | 24377455 | Nutrition | Effects of bayberry juice on inflammatory and apoptotic markers in young adults with features of non-alcoholic fatty liver disease. | 2014 | Details |
A22667 | 24375162 | Iran Biomed J | Prevention of nonalcoholic steatohepatitis in rats by two manganese-salen complexes. | 2014 | Details |
A22671 | 24373555 | Nutr J | Tocotrienols for normalisation of hepatic echogenic response in nonalcoholic fatty liver: a randomised placebo-controlled clinical trial. | 2013 | Details |
A22675 | 24322028 | Rom J Morphol Embryol | Effect of diet and omega-3 fatty acids in NAFLD. | 2013 | Details |
A22678 | 26528002 | Clujul Med | From NAFLD to Cardiovascular Disease. Is it (Still) the Metabolic Syndrome? | 2014 | Details |
A22705 | 24368431 | J Nutr | Choline supplementation protects against liver damage by normalizing cholesterol metabolism in Pemt/Ldlr knockout mice fed a high-fat diet. | 2013 | Details |
A22715 | 24361606 | Biochim Biophys Acta | Lipoic acid prevents fructose-induced changes in liver carbohydrate metabolism: role of oxidative stress. | 2013 | Details |
A22719 | 24358308 | PLoS One | A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice. | 2013 | Details |
A22720 | 24358045 | Hepat Mon | How Much Weight Loss is Effective on Nonalcoholic Fatty Liver Disease? | 2013 | Details |
A22723 | 24356885 | Am J Physiol Gastrointest Liver Physiol | Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease. | 2013 | Details |
A22748 | 24333444 | Biochem Biophys Res Commun | Mechanisms underlying hypertriglyceridemia in rats with monosodium L-glutamate-induced obesity: evidence of XBP-1/PDI/MTP axis activation. | 2013 | Details |
A22755 | 24327959 | Mol Metab | Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis. | 2013 | Details |
A22761 | 24325457 | J Med Food | The effects of α-lipoic acid on liver oxidative stress and free fatty acid composition in methionine-choline deficient diet-induced NAFLD. | 2013 | Details |
A22767 | 24321741 | Eur J Med Res | Dietary fructose enhances the incidence of precancerous hepatocytes induced by administration of diethylnitrosamine in rat. | 2013 | Details |
A22775 | 24316518 | J Hepatol | Dietary glycotoxins exacerbate progression of experimental fatty liver disease. | 2013 | Details |
A22792 | 24302567 | Mol Nutr Food Res | Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds. | 2013 | Details |
A22820 | 24286856 | Metabolism | Palmitate-induced activation of mitochondrial metabolism promotes oxidative stress and apoptosis in H4IIEC3 rat hepatocytes. | 2013 | Details |
A22825 | 24282628 | Oxid Med Cell Longev | Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease. | 2013 | Details |
A22826 | 24280560 | Med Hypotheses | Non-alcoholic fatty liver disease; a part of the metabolic syndrome in the renal transplant recipient and possible cause of an allograft dysfunction. | 2013 | Details |
A22836 | 24274878 | Clin Liver Dis | Host genetic variants in obesity-related nonalcoholic fatty liver disease. | 2013 | Details |
A22837 | 24274877 | Clin Liver Dis | The interactions of nonalcoholic fatty liver disease and cardiovascular diseases. | 2013 | Details |
A22851 | 24273892 | Pharmazie | Celastrus orbiculatus Thunb. ameliorates high-fat diet-induced non-alcoholic fatty liver disease in guinea pigs. | 2013 | Details |
A22860 | 24273273 | Nan Fang Yi Ke Da Xue Xue Bao | [Effects of glucagon-like peptide-1 on liver oxidative stress, TNF-α and TGF-β1 in rats with non-alcoholic fatty liver disease]. | 2013 | Details |
A22916 | 24214843 | Mol Nutr Food Res | Genistein alleviates the development of nonalcoholic steatohepatitis in ApoE(-/-) mice fed a high-fat diet. | 2013 | Details |
A22919 | 24211274 | Toxicol Appl Pharmacol | CYP2E1-dependent and leptin-mediated hepatic CD57 expression on CD8+ T cells aid progression of environment-linked nonalcoholic steatohepatitis. | 2013 | Details |
A22924 | 24206551 | Rev Esp Enferm Dig | Pathogenesis, diagnosis and treatment of non-alcoholic fatty liver disease. | 2013 | Details |
A22937 | 24192698 | Pediatr Res | Developmental origins of nonalcoholic fatty liver disease. | 2013 | Details |
A22938 | 24191237 | Redox Biol | Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation. | 2013 | Details |
A22954 | 24179614 | World J Hepatol | Lipotoxicity in the liver. | 2013 | Details |
A22957 | 24176233 | Nutr Res | Acetyl-L-carnitine and lipoic acid improve mitochondrial abnormalities and serum levels of liver enzymes in a mouse model of nonalcoholic fatty liver disease. | 2013 | Details |
A22965 | 24167955 | Arch Latinoam Nutr | Prevention of liver steatosis through fish oil supplementation: correlation of oxidative stress with insulin resistance and liver fatty acid content. | 2013 | Details |
A22968 | 24161595 | Exp Mol Pathol | Manganese superoxide dismutase is reduced in the liver of male but not female humans and rodents with non-alcoholic fatty liver disease. | 2013 | Details |
A22971 | 24157968 | Am J Physiol Gastrointest Liver Physiol | Purinergic receptor X7 is a key modulator of metabolic oxidative stress-mediated autophagy and inflammation in experimental nonalcoholic steatohepatitis. | 2013 | Details |
A22991 | 24132155 | Int J Mol Sci | Multiple hits, including oxidative stress, as pathogenesis and treatment target in non-alcoholic steatohepatitis (NASH). | 2013 | Details |
A22995 | 24130212 | Hum Exp Toxicol | Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease. | 2013 | Details |
A23002 | 24121055 | Toxicol Appl Pharmacol | Accumulation of lipids and oxidatively damaged DNA in hepatocytes exposed to particles. | 2013 | Details |
A23006 | 24119413 | BMC Complement Altern Med | Camel milk ameliorates steatohepatitis, insulin resistance and lipid peroxidation in experimental non-alcoholic fatty liver disease. | 2013 | Details |
A23012 | 24117897 | J Gastroenterol Hepatol | Effects of treatment with hydrogen sulfide on methionine-choline deficient diet-induced non-alcoholic steatohepatitis in rats. | 2014 | Details |
A23016 | 24115128 | Hepatology | Adaptive immune responses triggered by oxidative stress contribute to hepatic inflammation in NASH. | 2014 | Details |
A23021 | 24113587 | Int J Mol Sci | Role of hepatic progenitor cells in nonalcoholic fatty liver disease development: cellular cross-talks and molecular networks. | 2013 | Details |
A23025 | 24101088 | Obes Surg | Association between liver vitamin A reserves and severity of nonalcoholic fatty liver disease in the class III obese following bariatric surgery. | 2014 | Details |
A23031 | 24097666 | Toxicol Sci | The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease. | 2013 | Details |
A23038 | 24084729 | Int J Mol Sci | Development of nonalcoholic hepatopathy: contributions of oxidative stress and advanced glycation end products. | 2013 | Details |
A23058 | 25509913 | Lik Sprava | [Condition of lipid peroxidation and antioxidant system in patients with non-alcoholic fatty liver disease]. | 2015 | Details |
A23059 | 24073298 | World J Hepatol | Current role of fenofibrate in the prevention and management of non-alcoholic fatty liver disease. | 2013 | Details |
A23068 | 24067262 | Ann Hepatol | Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index. | 2014 | Details |
A23070 | 24066058 | PLoS One | Aldose reductase is involved in the development of murine diet-induced nonalcoholic steatohepatitis. | 2013 | Details |
A23073 | 24065295 | Int J Mol Med | Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study. | 2013 | Details |
A23076 | 24064383 | Free Radic Biol Med | CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis. | 2013 | Details |
A23081 | 24059726 | Mini Rev Med Chem | Hepatic diseases related to triglyceride metabolism. | 2013 | Details |
A23083 | 24055888 | Biochim Biophys Acta | tert-Butylhydroquinone (tBHQ) protects hepatocytes against lipotoxicity via inducing autophagy independently of Nrf2 activation. | 2013 | Details |
A23096 | 24042997 | Int J Mol Med | The chemical chaperon 4-phenylbutyric acid ameliorates hepatic steatosis through inhibition of de novo lipogenesis in high-fructose-fed rats. | 2013 | Details |
A23100 | 24040875 | Curr Pharm Des | The role of statins in the treatment of type 2 diabetes mellitus: an update. | 2014 | Details |
A23103 | 24039933 | PLoS One | Effects of indoleamine 2,3-dioxygenase deficiency on high-fat diet-induced hepatic inflammation. | 2013 | Details |
A23115 | 24028323 | Liver Int | Paraoxonase 1 and oxidative stress in paediatric non-alcoholic steatohepatitis. | 2013 | Details |
A23117 | 24028151 | Diabetes Technol Ther | Comparison of characteristics between nonobese and overweight/obese subjects with nonalcoholic fatty liver disease in a South Indian population. | 2013 | Details |
A23126 | 24020820 | APMIS | Highly expressed MT-ND3 positively associated with histological severity of hepatic steatosis. | 2013 | Details |
A23133 | 24015600 | Adv Clin Chem | Markers in nonalcoholic steatohepatitis. | 2013 | Details |
A23135 | 24011648 | Gastroenterol Hepatol | [Alcoholic and non-alcoholic steatohepatitis: who is affected and what can we do for them?]. | 2013 | Details |
A23149 | 24004441 | Free Radic Res | Involvement of free radicals and oxidative stress in NAFLD/NASH. | 2013 | Details |
A23163 | 23994574 | Free Radic Biol Med | Free radical biology for medicine: learning from nonalcoholic fatty liver disease. | 2013 | Details |
A23169 | 23834053 | Nutr Hosp | Other aspects of bariatric surgery: liver steatosis, ferritin and cholesterol metabolism. | 2013 | Details |
A23180 | 23981577 | Cancer Lett | Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions. | 2013 | Details |
A23185 | 23978414 | Food Chem Toxicol | Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease. | 2013 | Details |
A23228 | 23939604 | Am Fam Physician | Nonalcoholic fatty liver disease: diagnosis and management. | 2013 | Details |
A23230 | 23935829 | PLoS One | Serum uric acid and non-alcoholic fatty liver disease in non-diabetic Chinese men. | 2013 | Details |
A23255 | 23923077 | Int J Clin Exp Pathol | Effect of chronic psychosocial stress on nonalcoholic steatohepatitis in mice. | 2013 | Details |
A23258 | 23922466 | World J Gastroenterol | Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation. | 2013 | Details |
A23264 | 23917437 | Nutr Clin Pract | Pediatric nonalcoholic fatty liver disease. | 2013 | Details |
A23273 | 23909258 | Vnitr Lek | [Effects of GLP-1 (glucagon-like peptide 1) on liver]. | 2013 | Details |
A23281 | 23900008 | Food Chem Toxicol | The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease. | 2013 | Details |
A23284 | 26405460 | Clin Lipidol | Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis. | 2013 | Details |
A23285 | 26000142 | Auto Immun Highlights | Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis. | 2013 | Details |
A23303 | 23883694 | J Nutr Sci Vitaminol (Tokyo) | The effect of ethyl pyruvate supplementation on rat fatty liver induced by a high-fat diet. | 2013 | Details |
A23304 | 23880173 | Mitochondrion | Modulation of hepatic redox status and mitochondrial metabolism by exercise: therapeutic strategy for liver diseases. | 2013 | Details |
A23308 | 23876851 | Semin Cancer Biol | Obesity, insulin resistance, NASH and hepatocellular carcinoma. | 2013 | Details |
A23313 | 23855299 | J Gastroenterol Hepatol | Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches. | 2013 | Details |
A23316 | 23855293 | J Gastroenterol Hepatol | Retinoids and their target genes in liver functions and diseases. | 2013 | Details |
A23322 | 23871755 | Free Radic Biol Med | MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. | 2013 | Details |
A23324 | 23870449 | BMC Pediatr | Pediatric non alcoholic fatty liver disease: more on novel treatment targets. | 2013 | Details |
A23343 | 23856494 | Food Chem Toxicol | Glutathione defense mechanism in liver injury: insights from animal models. | 2013 | Details |
A23348 | 23851679 | Food Funct | Oat β-glucan inhibits lipopolysaccharide-induced nonalcoholic steatohepatitis in mice. | 2013 | Details |
A23360 | 23843692 | Drug Des Devel Ther | S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. | 2013 | Details |
A23364 | 23842931 | Acta Cir Bras | Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease. | 2013 | Details |
A23373 | 23835912 | Clin Obstet Gynecol | Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the"first hit". | 2013 | Details |
A23398 | 23815295 | Aging Cell | Liver diseases and aging: friends or foes? | 2013 | Details |
A23410 | 23805238 | PLoS One | High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats. | 2013 | Details |
A23429 | 23792160 | FEBS Lett | Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production. | 2013 | Details |
A23449 | 23770462 | Mol Cell Endocrinol | Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease. | 2013 | Details |
A23463 | 23758436 | Clin Sci (Lond) | Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice. | 2013 | Details |
A23466 | 23755269 | PLoS One | Lepr(db/db) Mice with senescence marker protein-30 knockout (Lepr(db/db)Smp30(Y/-)) exhibit increases in small dense-LDL and severe fatty liver despite being fed a standard diet. | 2013 | Details |
A23480 | 23743495 | Redox Rep | The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis. | 2013 | Details |
A23481 | 23742138 | J Agric Food Chem | Altered hepatic gene expression profiles associated with improved fatty liver, insulin resistance, and intestinal permeability after hydroxypropyl methylcellulose (HPMC) supplementation in diet-induced obese mice. | 2013 | Details |
A23491 | 23733885 | J Lipid Res | Deficiency of liver Comparative Gene Identification-58 causes steatohepatitis and fibrosis in mice. | 2013 | Details |
A23522 | 23711137 | Am J Chin Med | Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats. | 2013 | Details |
A23524 | 23707663 | Biochim Biophys Acta | Inhibition of CYP2E1 leads to decreased advanced glycated end product formation in high glucose treated ADH and CYP2E1 over-expressing VL-17A cells. | 2013 | Details |
A23540 | 23698776 | Int J Mol Sci | Obesity-associated oxidative stress: strategies finalized to improve redox state. | 2013 | Details |